MIDDLETOWN — Since her mother has Alzheimer’s disease, Maggie Goonan considers herself to be at high risk for the illness.
So she had been tracking the progress of the drug lecanemab …
Join our family of readers for as little as $14.99 per month and support local, unbiased journalism.
Already a member? Log in to continue. Otherwise, follow the link below to join.
Please log in to continue |